Next Article in Journal
An Exonuclease I-Aided Turn-Off Fluorescent Strategy for Alkaline Phosphatase Assay Based on Terminal Protection and Copper Nanoparticles
Previous Article in Journal
Bioengineering of Genetically Encoded Gene Promoter Repressed by the Flavonoid Apigenin for Constructing Intracellular Sensor for Molecular Events

In Situ LSPR Sensing of Secreted Insulin in Organ-on-Chip

Biosensors for Bioengineering Group, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Baldiri I Reixac, 10-12, 08028 Barcelona, Spain
Plasmon Nano-Optics Group, ICFO-Institute for Photonics Sciences, The Barcelona Institute of Science and Technology, 08860 Barcelona, Spain
Diabetes and Obesity Research Laboratory, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas (CIBERDEM), 28029 Madrid, Spain
Nanophotonic Systems Laboratory, Department of Mechanical and Process Engineering, ETH Zurich, 8092 Zurich, Switzerland
ICREA-Institució Catalana de Recerca i Estudis Avançats, 08010 Barcelona, Spain
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Biosensors 2021, 11(5), 138;
Received: 19 March 2021 / Revised: 17 April 2021 / Accepted: 25 April 2021 / Published: 28 April 2021
Organ-on-a-chip (OOC) devices offer new approaches for metabolic disease modeling and drug discovery by providing biologically relevant models of tissues and organs in vitro with a high degree of control over experimental variables for high-content screening applications. Yet, to fully exploit the potential of these platforms, there is a need to interface them with integrated non-labeled sensing modules, capable of monitoring, in situ, their biochemical response to external stimuli, such as stress or drugs. In order to meet this need, we aim here to develop an integrated technology based on coupling a localized surface plasmon resonance (LSPR) sensing module to an OOC device to monitor the insulin in situ secretion in pancreatic islets, a key physiological event that is usually perturbed in metabolic diseases such as type 2 diabetes (T2D). As a proof of concept, we developed a biomimetic islet-on-a-chip (IOC) device composed of mouse pancreatic islets hosted in a cellulose-based scaffold as a novel approach. The IOC was interfaced with a state-of-the-art on-chip LSPR sensing platform to monitor the in situ insulin secretion. The developed platform offers a powerful tool to enable the in situ response study of microtissues to external stimuli for applications such as a drug-screening platform for human models, bypassing animal testing. View Full-Text
Keywords: LSPR sensors; organ-on-a-chip; in situ insulin monitoring LSPR sensors; organ-on-a-chip; in situ insulin monitoring
Show Figures

Figure 1

MDPI and ACS Style

Ortega, M.A.; Rodríguez-Comas, J.; Yavas, O.; Velasco-Mallorquí, F.; Balaguer-Trias, J.; Parra, V.; Novials, A.; Servitja, J.M.; Quidant, R.; Ramón-Azcón, J. In Situ LSPR Sensing of Secreted Insulin in Organ-on-Chip. Biosensors 2021, 11, 138.

AMA Style

Ortega MA, Rodríguez-Comas J, Yavas O, Velasco-Mallorquí F, Balaguer-Trias J, Parra V, Novials A, Servitja JM, Quidant R, Ramón-Azcón J. In Situ LSPR Sensing of Secreted Insulin in Organ-on-Chip. Biosensors. 2021; 11(5):138.

Chicago/Turabian Style

Ortega, María A., Júlia Rodríguez-Comas, Ozlem Yavas, Ferran Velasco-Mallorquí, Jordina Balaguer-Trias, Victor Parra, Anna Novials, Joan M. Servitja, Romain Quidant, and Javier Ramón-Azcón. 2021. "In Situ LSPR Sensing of Secreted Insulin in Organ-on-Chip" Biosensors 11, no. 5: 138.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop